慢性阻塞性肺病中的DOSE指数:评估医疗保健成本
Chin-Ling Li1, Hui-Chuan Chang1, Ching-Wan Tseng1
1Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan.
BMC pulmonary medicine
|November 8, 2024
概括
包含呼吸障碍,阻塞,吸烟和恶化症的DOSE指数显示,它对预测COPD患者的医疗费用充满希望. 它包含了恶化的情况,使其成为经济评估的有价值工具.
科学领域:
- 肺部病理学 肺部病理学
- 卫生经济学 卫生经济学
- 医疗信息学 医疗信息学
背景情况:
- 用于评估COPD的严重程度和预后,建立了DOSE指数 (呼吸不全,阻塞,吸烟,恶化).
- 慢性肺炎的医疗费用在很大程度上是由恶化引起的.
- 像BODE和ADO这样的现有指数缺乏对医疗保健成本预测的具体关注.
研究的目的:
- 评估DOSE指数在预测慢性阻塞性肺病 (COPD) 患者的医疗保健成本方面的潜力.
- 将DOSE指数的预测性能与其他指数进行比较,包括BODE,ADO和查尔森并发症指数 (CCI).
主要方法:
- 一项涉及396名COPD患者的横截面回顾性研究.
- 对DOSE,BODE,ADO,CCI与直接医疗保健成本 (住院治疗,急诊室访问) 之间的关联进行分析.
- 将医疗保健费用分类为直接医疗费用.
主要成果:
- DOSE指数显示出与门诊访问和开支的显著相关性 (p=0.013,p=0.011).
- 较高的DOSE四分位数与增加的住院频率,持续时间和成本 (p<0.001) 有很强的相关性.
- 与其他指数相比,DOSE指数的表现优于其他指数,这是由于它包含了恶化数据.
结论:
- DOSE指数显示了预测COPD相关医疗保健成本的巨大潜力,主要是因为它侧重于恶化频率.
- 将恶化的情况纳入风险评估,可以更准确地预测COPD管理中的经济负担.
- DOSE指数可以作为COPD患者临床和经济评估的有价值工具.
更多相关视频
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:23Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182